Glatiramer acetate controlled release - Mapi Pharma

Drug Profile

Glatiramer acetate controlled release - Mapi Pharma

Alternative Names: GA Depot; GA long-acting injection; Glatiramer acetate depot formulation - Mapi Pharma; Glatiramer acetate long-acting formulation - Mapi Pharma; Glatiramer acetate microspheres

Latest Information Update: 12 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mapi Pharma
  • Class Peptides; Polymers
  • Mechanism of Action Immunomodulators; MHC class II gene modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Multiple sclerosis

Most Recent Events

  • 10 Apr 2018 Glatiramer Acetate controlled release licensed to Mylan for global marketing
  • 10 Apr 2018 Mapi Pharma announces intention to submit IND application to global health authoritis for Multiple sclerosis
  • 11 Dec 2017 Mapi Pharma initiates enrolment in a phase II trial for Multiple sclerosis (Primary progressive mutliple sclerosis) in Israel (NCT03362294)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top